Key facts
- Notable investors include Founderville.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for WaiveDx
- ·The full record, as it builds
Funding rounds
No funding rounds for WaiveDx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About WaiveDx
Operator of a precision health technology platform intended to deliver personalized health outcomes across clinical and government markets. The company's platform automates clinical interpretation, regulatory compliance, genomic data management, and pharmacogenomic analysis, enabling healthcare providers and government programs to make faster, data-driven, personalized health decisions at scale.
- Sector
- Healthcare
- HQ
- Greenville, SC, United States
- Website
- waivedx.ai/
- Ownership
- Acquired/Merged (Operating Subsidiary)
WaiveDx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WaiveDx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WaiveDx in its N-PORT filings yet. We sweep new filings monthly.